IDHIFA® (enasidenib) for Patients

Web Name: IDHIFA® (enasidenib) for Patients

WebSite: http://www.idhifa.com

ID:349776

Keywords:

enasidenib,IDHIFA,Patients,for

Description:


angle-downcancelchevron-downclose-xdownload-iconhome3link_iconmailth-menusearchsearch-plussharethree-bars

For questions about BMS medicines during this time please call 1-800-721-8909.

IDHIFA

® (enasidenib) is a prescription medicine used to treat people with acute myeloid leukemia (AML)
with an isocitrate dehydrogenase-2 (IDH2) mutation whose disease has come back or has not improved after previous treatment(s).
It is not known if IDHIFA® is safe and effective in children.

How does
IDHIFA® work?

Learn How

How should I
take IDHIFA®?

Learn More

What resources are
available for my
caregiver and me?

Discover Resources

Model used for illustrative purposes only

Patient
Brochure

DownloadDescargar en español

Idhifa® Wallet Cards

DownloadDescargar en español

What is AML?

Learn More

WHAT IS IDHIFA® (enasidenib)?

IDHIFA® is a prescription medicine used to treat people with acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation whose disease has come back or has not improved after previous treatment(s). It is not known if IDHIFA is safe and effective in children.

ToggleToggle

IMPORTANT SAFETY INFORMATION

What is the most important information I should know about IDHIFA?

IDHIFA may cause serious side effects, including:

Differentiation Syndrome. Differentiation syndrome is a condition that affects your blood cells which may be life-threatening or lead to death if not treated. Differentiation syndrome has happened within 1 day and up to 5 months after starting IDHIFA. Call your healthcare provider or go to the nearest hospital emergency room right away if you develop any of the following symptoms of differentiation syndrome while taking IDHIFA:fevercoughshortness of breathswelling of arms and legsswelling around neck, groin, or underarm areafast weight gain (greater than 10 pounds within a week)bone pain

If you develop any of these symptoms of differentiation syndrome, your healthcare provider may start you on a medicine taken by mouth or given through a vein (intravenous) called corticosteroids and may monitor you in the hospital.

Toggle

Before taking IDHIFA, tell your healthcare provider about all of your medical conditions, including if you:

Are pregnant, plan to become pregnant, or think you might be pregnant during treatment with IDHIFA. IDHIFA can cause harm to your unborn baby if taken during pregnancyIf you are able to become pregnant, your healthcare provider will do a pregnancy test before you start taking IDHIFAFemales who are able to become pregnant and who take IDHIFA should use effective birth control (contraception) during treatment with IDHIFA and for at least 2 months after your last dose of IDHIFAMales who have female partners that are able to become pregnant should use effective birth control during treatment with IDHIFA and for at least 2 months after your last dose of IDHIFAIDHIFA may affect how hormonal contraceptives work and may cause them to not work as wellTalk to your healthcare provider about birth control methods that may be right for you while taking IDHIFAIDHIFA may cause fertility problems in females and males, which may affect your ability to have children. Talk to your healthcare provider if you have concerns about fertilityAre breastfeeding or plan to breastfeed. It is not known if IDHIFA passes into your breast milk. You should not breastfeed during your treatment with IDHIFA and for at least 2 months after your last dose of IDHIFA

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

How should I take IDHIFA?

Take IDHIFA exactly as your healthcare provider tells you toTake IDHIFA 1 time a day at the same time each day. IDHIFA can be taken with or without foodSwallow IDHIFA tablets whole with 8 ounces (one cup) of water. Do not chew or split the tabletIf you miss a dose of IDHIFA or vomit after taking a dose of IDHIFA, take the dose of IDHIFA as soon as possible on the same day. Then take your next dose the next day at your regularly scheduled time. Do not take 2 doses at the same time to make up for the missed doseYour healthcare provider should do blood tests to check your blood counts before you start IDHIFA treatment and at a minimum of every 2 weeks for at least the first 3 months during treatment to check for side effects

What are the possible side effects of IDHIFA?

IDHIFA may cause serious side effects, including:

See "What is the most important information I should know about IDHIFA?"

The most common side effects of IDHIFA include:

nauseavomitingdiarrheajaundicedecreased appetite

Tell your healthcare provider if you have any changes to the color of your skin or the whites of your eyes.

Your healthcare provider will monitor you for side effects during treatment and may tell you to stop taking IDHIFA if you develop certain side effects. These are not all the possible side effects of IDHIFA. Call your doctor for medical advice about side effects. You may report side effects to FDA at 
1-800-FDA-1088.

General information about the safe and effective use of IDHIFA

Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not take IDHIFA for conditions for which it was not prescribed. Do not give IDHIFA to other people, even if they have the same symptoms you have. It may harm them. You can ask your pharmacist or healthcare provider for information about IDHIFA that is written for health professionals.

Please see full Prescribing Information, including Boxed WARNING and Medication Guide.

© 2022 Bristol-Myers Squibb Company.
IDHIFA is a trademark of Celgene Corporation, a Bristol Myers Squibb company.
Access Support is a registered trademark of Bristol-Myers Squibb Company.
IDHIFA is licensed from Servier Pharmaceuticals, LLC.

Complete the form below to share this page.

Please choose an option:

Visit Healthcare Professional Site

The information contained in this website is intended for U.S. audiences only.


This website is intended for US healthcare professionals only.

/prescribing-information/

TAGS:enasidenib IDHIFA Patients for

<<< Thank you for your visit >>>

Websites to related :
Connecting Patients to Their Tru

  Skip to main content Close Search Menu ProvidersProvidersPediatric Virtual Care SolutionsPediatric Urgent CareAnytime After HoursP

Polestar Calendars | Agendas for

  "); } else { win._boomrl = function() { bootstrap(); }; if (win.addEventListener) { win.addEventListener("load", win._

Home - California Retailer's Ass

  Skip to contentMain MenuWho We AreWhy You Should JoinAdvocacyContactResourcesCal ORCAEventsNewsAssociate MembershipsCRA LeadershipCRA CommitteesAuror

Grayken Center for Addiction TTA

   LoginCreate accountA Resource for Healthcare and SocialServicesProfessionalsHomeMAT Quick StartTrainingPre-recorded TrainingsTrainingsRequest TTAProj

11-Counter.com is for sale | Hug

  Questions?+1-303-893-0552HomeFAQsAbout usContact usMy accountMy favoritesShopping cart11-Counter.comBuy now:$4,695&#9656; Buy nowProcessingor&#9656; S

New Tahoe Yukon Forum

  Login / JoinWhat's NewForum ListingShowcaseGalleryAdvanced SearchMembersFAQDark ModeMenuLog inRegisterJavaScript is disabled. For a better experience,

Log a Load for Kids

  HomeNewsState Contacts and Member HospitalsFAQResourcesDonateContact UsMenuHomeNewsState Contacts and Member HospitalsFAQResourcesDonateContact UsCari

Buy Domains - bestchiller.com is

   bestchiller.com This domain name is for sale
Give us a call (781) 373-6820

CK2 Consulting | Experts in busi

   HOMESERVICESABOUTCONTACT Select Page Experts in Business TransformationProject failure normally is a result of attention and focus on the human

Rape Porn Videos - Gagged And Ra

   RapePornVideos

ads

Hot Websites